A synbiotic mixture of scGOS/lcFOS and Bifidobacterium breve M-16V increases faecal Bifidobacterium in healthy young children

被引:8
|
作者
Kosuwon, P. [1 ]
Lao-Araya, M. [2 ]
Uthaisangsook, S. [3 ]
Lay, C. [4 ]
Bindels, J. [4 ]
Knol, J. [5 ,6 ]
Chatchatee, P. [7 ]
机构
[1] Khon Kaen Univ, Fac Med, Dept Paediat, 123 Mittrapab Rd, Khon Kaen 40002, Thailand
[2] Chiang Mai Univ Hosp, 110 Suthep Rd Tambon Su Thep, Chiang Mai 50200, Thailand
[3] Naresuan Univ, Fac Med, Dept Paediat, 99 Moo 9,9,Phitsanulok Nakhon Sawan Rd, Mueang Phitsanulok 65000, Phitsanulok, Thailand
[4] Danone Nutricia Res, 30 Biopolis St,05-01B, Singapore 138671, Singapore
[5] Danone Nutricia Res, Utrecht, Netherlands
[6] Wageningen Univ, Lab Microbiol, POB 7005, NL-6700 CA Wageningen, Netherlands
[7] King Chulalongkorn Mem Hosp, 1873,Rama 4 Rd, Bangkok 10330, Thailand
关键词
healthy toddlers; gut microbiota; synbiotic; Bifidobacterium; stool consistency; IN-SITU HYBRIDIZATION; CHAIN FATTY-ACIDS; GUT MICROBIOTA; ATOPIC-DERMATITIS; INFANTS; BACTERIA; OLIGOSACCHARIDES; FORMULA; INTERPLAY; RESPONSES;
D O I
10.3920/BM2017.0110
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Little is known about the impact of nutrition on toddler gut microbiota. The plasticity of the toddler gut microbiota indicates that nutritional modulation beyond infancy could potentially impact its maturation. The objective of this study was to determine the effect of consuming Young Child Formula (YCF) supplemented with short chain galactooligosaccharides and long chain fructooligosaccharides (scGOS/lcFOS, ratio 9:1) and Bifidobacterium breve M-16V on the development of the faecal microbiota in healthy toddlers. A cohort of 129 Thai children aged 1-3 years were included in a randomised controlled clinical study. The children were assigned to receive either YCF with 0.95 g/100 ml of scGOS/lcFOS and 1.8x107 cfu/g of B. breve M-16V (Active-YCF) or Control-YCF for 12 weeks. The composition and metabolic activity of the faecal microbiota, and the level of secretory immunoglobulin A were determined in the stool samples. The consumption of Active-YCF increased the proportion of Bifidobacterium (mean 27.3% at baseline to 33.3%, at week 12, P=0.012) with a difference in change from baseline at week 12 between the Active and Control of 7.48% (P=0.030). The consumption of Active-YCF was accompanied with a more acidic intestinal milieu compared to the Control-YCF. The pH value decreased statistically significantly in the Active-YCF group from a median of 7.05 at baseline to 6.79 at week 12 (P<0.001). The consumption of Active-YCF was associated with a softer pudding-like stool consistency compared to the Control-YCF. At week 6 and week 12, the between-group difference in stool consistency was statistically significant (P=0.004 and P<0.001, respectively). A Young Child Formula supplemented with scGOS/lcFOS and B. breve M-16V positively influences the development of the faecal microbiota in healthy toddlers by supporting higher levels of Bifidobacterium. The synbiotic supplementation is also accompanied with a more acidic intestinal milieu and softer stools.
引用
收藏
页码:541 / 552
页数:12
相关论文
共 36 条
  • [31] Probiotic characteristics and in vitro compatibility of a combination of Bifidobacterium breve M-16 V, Bifidobacterium longum subsp. infantis M-63 and Bifidobacterium longum subsp. longum BB536
    Marco Toscano
    Elena De Vecchi
    Arianna Gabrieli
    Gian Vincenzo Zuccotti
    Lorenzo Drago
    Annals of Microbiology, 2015, 65 : 1079 - 1086
  • [32] Infant formula containing galacto-and fructo-oligosaccharides and Bifidobacterium breve M-16V supports adequate growth and tolerance in healthy infants in a randomised, controlled, double-blind, prospective, multicentre study
    Abrahamse-Berkeveld, M.
    Alles, M.
    Franke-Beckmann, E.
    Helm, K.
    Knecht, R.
    Koellges, R.
    Sandner, B.
    Knol, J.
    Ben Amor, K.
    Bufe, A.
    JOURNAL OF NUTRITIONAL SCIENCE, 2016, 5
  • [33] Bifidobacterium breve M-16V alters the gut microbiota to alleviate OVA-induced food allergy through IL-33/ST2 signal pathway
    Li, Na
    Yu, Yi
    Chen, Xuehua
    Gao, Shenshen
    Zhang, Qingqing
    Xu, Chundi
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (12) : 9464 - 9473
  • [34] Outcomes in preterm small versus appropriate for gestation infants after Bifidobacterium breve M-16 V supplementation
    Athalye-Jape, Gayatri
    Minaee, Novia
    Nathan, Elizabeth
    Simmer, Karen
    Patole, Sanjay
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2020, 33 (13): : 2209 - 2215
  • [35] Dietary intervention with β-lactoglobulin-Derived Peptides and a specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates the Prevention of Whey-induced allergy in Mice by supporting a Tolerance-Prone immune environment
    Kostadinova, Atanaska I.
    Pablos-Tanarro, Alba
    Diks, Mara A. P.
    van Esch, Betty C. A. M.
    Garssen, Johan
    Knippels, Leon M. J.
    Willemsen, Linette E. M.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [36] Difficulties in developmental follow-up of preterm neonates in a randomised-controlled trial of Bifidobacterium breve M16-V - Experience from Western Australia
    Agrawal, S.
    Pestell, C. F.
    Granich, J.
    Rao, S.
    Nathan, E.
    Wray, J. A.
    Whitehouse, A. J. O.
    Patole, S.
    EARLY HUMAN DEVELOPMENT, 2020, 151